News & Media

NASDAQ Latest Announcements

For media opportunities, enquire now

Enquire Now

Historic Company Announcements

DateDescriptionView
Aug 30, 2023Annual Report and Appendix 4E
Aug 30, 2023Clarification to Top 20 in Annual Report
Aug 24, 2023Incannex to Prepare IND Application for Psi-GAD
Aug 22, 2023US FDA Completes Review of IHL-42x IND Application
Aug 10, 2023IHL Provides Shareholder Information Events for Redomiciling
Aug 9, 2023Change of Director’s Interest Notice
Aug 8, 2023Psychedelic Treatment Registrations start at Clarion Clinics
Aug 1, 2023Incannex Provides Access to Advisory Firm for Redomicile
Jul 28, 2023Quarterly Activities and Appendix 4C Cash Flow Report
Jul 26, 2023IHL Completes Pre-IND Meeting with US FDA on IHL-675A
Showing 21 to 30 of 1128 announcements
1 2 3 4 5 113

Historical results and presentations

Investor inquiries

For investor related enquiries please contact
Brad Dilkes: investors@incannex.com.au

Media inquiries

For press and media related enquiries please contact
Joel Latham: admin@incannex.com.au

Subscribe and stay connected

Stay up to date with Incannex’s leading research and development programs, multiple secondary assets, investor relations and biotechnology advancements.

"*" indicates required fields